Improving Quality And Diffusing Best Practices: The Case Of Schizophrenia

Western Psychiatric Institute and Clinic, University of Pittsburgh (Pennsylvania) Medical School, USA.
Health Affairs (Impact Factor: 4.97). 05/2009; 28(3):701-12. DOI: 10.1377/hlthaff.28.3.701
Source: PubMed


The slow spread of treatments supported by empirical evidence and the rapid diffusion of treatments lacking such support play major roles in the lower quality of mental health care received by people with severe mental illnesses compared with the care of less severely ill people. Further, the rapid spread of treatments that are of low cost-effectiveness limits the system's ability to provide the full gamut of high-value treatments available to treat this vulnerable population. Using the case of schizophrenia, we review the context in which these paradoxical patterns of diffusion have occurred, and we propose policy solutions.

Full-text preview

Available from:

  • No preview · Article · May 2010 · Behavioral healthcare
  • [Show abstract] [Hide abstract]
    ABSTRACT: Police agencies across the country are struggling to respond to significant number of persons with serious mental illness, who are landing on their doorsteps with sometimes tragic consequences. Arguably, the most widely adopted approach, the Crisis Intervention Team (CIT) model, is a specialized police-based program designed to improve officers’ ability to safely and effectively respond to mental health crises. Conducting research on CIT is challenging; thus, the evidence base is limited. In this article, the author reviews the emerging literature, present a conceptual model of CIT effectiveness, and describe a study of CIT in Chicago. Findings from Chicago suggest that CIT is increasing linkage to services and reducing use of force in encounters with persons with mental illness. Lessons learned are discussed.
    No preview · Article · Aug 2010 · Research on Social Work Practice
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the past, when an apothecary individually compounded medications; Polypharmacy was referred to the mixing of many drugs in one prescription. Today Polypharmacy implies to the prescription of too many medications for an individual patient, with an associated higher risk of adverse drug reactions and interactions. Situations certainly exist where the use of multiple medications is justified in order to yield effective pharmacotherapy. Polypharmacy is a problem of substantial importance, in terms of both direct medication costs and indirect medication costs resulting from drug-related morbidity. Moreover it is a preventable problem. Available data suggests physicians and clinical pharmacists have the potential to have a large effect in combating this problem through a variety of interventions such as reducing the number of medications taken, reducing the number of doses taken, increasing patient adherence, preventing adverse drug reactions (ADRs), improving patient quality of life and decreasing facility and drug costs. In this article, we describe how Polypharmacy might occur and what complications cause, we review studies evaluating interventions to reduce unnecessary prescribing, and finally; we identify practical means for the busy physician to avoid this problem.
    No preview · Article · Nov 2010 · International Journal of Pharmaceutical Sciences Review and Research
Show more